
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67210
Radiology
Orthopedics
Enchondroma in the Fibular Diaphysis: A Case Report
Muacevic Alexander
Adler John R
Costache Mihai Aurel 1
Iordache Sergiu 1
Cursaru Adrian 1
Popa Mihnea 1
Serban Bogdan 1
Cretu Bogdan 1
Marinescu Andreea 2
Cirstoiu Catalin 1
1 Orthopaedics and Traumatology, University Emergency Hospital, Bucharest, ROU
2 Radiology and Imaging, University Emergency Hospital, Bucharest, ROU
Sergiu Iordache sergiu.iordache92@yahoo.com
19 8 2024
8 2024
16 8 e6721019 8 2024
Copyright © 2024, Costache et al.
2024
Costache et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/279545-enchondroma-in-the-fibular-diaphysis-a-case-report
Chondroma is a benign tumor formation that occurs through the proliferation of cartilaginous tissue. It can be located centrally (enchondroma) or peripherally, often appears between 10-30 years of age, and is commonly discovered incidentally. This case report describes a 46-year-old woman presenting with pain in the left calf and partial functional impotence. The onset of her symptoms was affirmatively marked by a mild skiing-related trauma. Following protocol, X-ray imaging (antero-posterior and lateral views) of the calf was performed, with the only finding being a solitary bony lesion, with internal calcifications, sclerotic margin and radiolucent internal matrix. Facing the uncertainty of diagnosis from a clinical and radiographic standpoint, it was decided to admit the patient for further evaluation and start the standard protocol of imaging investigations - computed tomography, magnetic resonance imaging, and bone scintigraphy - and determine the subsequent therapeutic behavior. Differential diagnosis between enchondroma and low-grade chondrosarcoma can be difficult due to their histopathological similarity. The therapy of choice in enchondroma comprises non-surgical treatment (observation) if the lesion remains unaltered in imaging, or curettage/filling with bone substitutes/allografts, but considering the advanced age and interruption of the bone cortex in our case, we opted for curative surgical treatment.

treatment choices
enchondroma
fibula fracture
resection
bone tumors
==== Body
pmcIntroduction

Bone tumor can be defined as a new growth of tissue that is characterized by uncontrolled growth of abnormal cells. Bone tumors represent an important chapter in musculoskeletal pathology. The most common benign tumors that occur in the locomotor system are chondroma, osteoid osteoma, giant cell tumor, aneurysmal cyst, and fibroblastic dysplasia [1].

Chondroma is a benign tumor formation that occurs through the proliferation of cartilaginous tissue. It can be located centrally (enchondroma) or peripherally. Enchondroma represents 13% of benign bone tumor cases, which are frequently located at the metaphyses of long bones. Among long bones, chondroma commonly occurs in the metaphyseal regions, especially those of the proximal humerus and distal femur, and less commonly in the proximal tibia (0.7%) or fibula (0.2%), or in flat ostea such as the pelvic bone and ribcage, leading to challenges in diagnosis [2].

Usually, enchondroma is asymptomatic and discovered incidentally during a routine check-up, with an average age of appearance of 10-30 years [3-5]. The process of diagnosing bone tumors relies on clinical aspects and proper imaging techniques, where differentiating between benign or malignant tumor formation is established on the basis of anatomopathological and immunohistochemical examination. This differentiation is relevant in the context of initiating the right course of treatment.

Case presentation

A 46-year-old woman presented to our Emergency Orthopedics & Trauma Room with pain in her left calf and partial functional impotence. The onset of her symptoms was affirmatively marked by a mild skiing-related trauma. Clinical-anamnestic examination indicated a spontaneous debut of the pain resulting from blunt injury to the lateral side of the left calf, which gradually intensified during physical exercise. Conservatory treatment with non-steroidal anti-inflammatory drugs (NSAIDs) did not successfully alleviate the symptoms. Local examination failed to reveal positive Celsian signs or bruising.

Following protocol, X-rays (antero-posterior and lateral views) of the calf were performed, with the only finding being a solitary bony lesion measuring approximately 12/14 mm in the coronal plane located in the distal 1/3 fibula shaft (Figure 1). The lesion has an eccentric location, a well-defined sclerotic margin and the internal matrix appears predominantly radiolucent, with possible internal calcifications. Also, there is mild cortical thinning over the lesion, but no evidence of cortical breakthrough or periosteal reaction on X-ray which suggests the lesion is likely slow-growing; the surrounding soft tissues appear unremarkable, with no visible soft tissue mass or edema. Considering the appearance of the tumor formation on X-ray, the differential diagnosis at this stage is made between enchondroma, non-ossifying fibroma, fibrous dysplasia and of course chondrosarcoma.

Figure 1 X-ray view of the distal 1/3 of the fibula shaft

A - antero-posterior view

B - lateral (profile) view

Upon admission to our department, from a biological point of view, the patient did not show changes in blood count (Table 1).

Table 1 Laboratory values of the patient at baseline

Biochemical Data	Patient’s Value	Normal Range	
WBC (white blood cells)	9.3	3.8–11.8 × 103/μL	
HGB (hemoglobin)	12.9	10.9–14.3 g/dL	
PLT (platelets)	345	179–408 × 103/μL	
Fibrinogen	315	238–498 mg/dL	
ALKP (alkaline phosphatase)	54	40–136 U/L	
Fe (iron)	110	50–160 mg/dL	
CRP (C-reactive protein)	0.4	0–5 mg/L	
Breast tumor marker CA 15-3	11.3	0-31.3 U/mL	
Ovarian tumor marker CA 125	13.5	0–35 U/mL	
Gastric tumor marker CA 19-9	5.4	0–35 U/mL	

Facing the uncertainty of diagnosis from a clinical and radiographic standpoint, we aimed to rule out a low-grade chondrosarcoma. Consequently, computed tomography (CT) scans of the thorax, abdomen, and pelvis (TAP), and the left calf were performed. No occult malignancies were identified in the TAP regions; in contrast, on the shaft of the left fibula, we were able to localize an osseous lesion that increased the diameter of the distal diaphysis, with dimensions of 12-14 mm transaxially, extending over a length of approximately 22 mm, which caused the thinning of the bone cortex and presented a fracture path involving the postero-lateral cortex, without displacement or changes in the adjacent soft tissues (Figure 2).

Figure 2 Computed tomography (CT) scan distal 1/3 of the fibula shaft before surgery

A - coronal view

B - axial view

Magnetic resonance imaging (MRI) was performed at the level of the calf. It revealed an intraosseous osteolytic lesion centered at the level of the medullary canal. The lesion thinned the posterior cortical bone, which was highlighted in the inferior third of the fibula. Moreover, a discontinuity of cortex was observed at the level of the lesion which measured approximately 29 mm in the cranio-caudal plane and 14-16 mm in the axial plane. Intramedullary millimeter nodular lesions were also observed inside the tumor formation in the distal 1/3 of the fibula shaft (Figure 3).

Figure 3 Magnetic resonance imaging (MRI) distal 1/3 of the fibula shaft before surgery

A - sagittal view

B - coronal view

C - axial view

To further analyze the characteristics of the lesion, a whole-body bone scintigraphy was performed. An intensely metabolically active osseous process at the level of the inferior third of the left fibula was identified, visible in all phases (Figure 4).

Figure 4 Bone scintigraphy (whole body scan) highlighting the bone lesion in the left fibula

Managing potential malignancies of the musculoskeletal system is a challenge that demands rigorous preoperative strategies. The choice of surgical approach is of utmost importance, especially when considering biopsies, as the surgeon ought to minimize the further spreading of the tumor cells and concomitantly determine the proper level of resection with oncological margins.

In the next step, we carried out an excisional biopsy/resection of the fibular lesion within oncological limits, accessing the inferior third of the peroneal region directly via a lateral incision (Figures 5, 6).

Figure 5 Intraoperative image

A - resection area of the tumor

B - intradermal suture

Figure 6 Macroscopic image of the resected bone lesion

The resection piece of bone was sent for histopathological examination, in which proliferations of chondrocytes grouped in lobules with low cell density, and a relatively monomorphic and slightly hyperchromic nucleus were identified, arguing for the diagnosis of benign tumor formation, more precisely enchondroma. In addition, resection limits were sent, this one being without tumor invasion (Figure 7).

Figure 7 Histopathological image

A - Intramedullary enchondromatous lesion consisting of hyaline cartilage with a slightly lobulated interlamellar arrangement

B - hypocellular intramedullary chondroid tumor proliferation formed by basophilic matrix and chondroblasts organized in dyads, with the bone cortex unaffected

At discharge, the patient was prescribed an anticoagulant, anodynes, and NSAIDs. She underwent specialized post-surgical recovery and care in a clinic designated for such patients. After only two weeks, her symptoms significantly diminished. Given the psychological aftermath of such an affliction, it was recommended that the patient be included in a psycho-medical rehabilitation program.

At a 45-day post-operative check-up, the patient fully supported herself on the left calf with no complaints (Figures 8, 9).

Figure 8 X-ray view after surgery

A - antero-posterior view

B - lateral view

Figure 9 Post-operative image at the 45-day control

The patient was recommended to continue the recovery program and come for periodic reassessment.

Discussion

Enchondroma is routinely identified solely by its radiological features alone. According to the World Health Organization, the diagnostic criteria for enchondroma are as follows: presence of cartilaginous matrix, absence of cortical invasion, absence of extension in the soft parts, and absence of cellular atypia [6-7]. A differential diagnosis is made with low-grade chondrosarcoma, and bone infarction [8]. Treatment can be non-surgical or surgical. The non-surgical and most common treatment in the case of enchondroma is follow-up through periodic imaging investigations, whereas surgical treatment consists of curettage-filling with allografts/bone substitute or resection.

The main purpose of this study was to establish management guidance in the case of enchondroma. The WHO (World Health Organization) in 2013 renamed low-grade chondrosarcoma as “atypical cartilaginous tumor” [8].

The potential for an enchondroma to progress into a secondary chondrosarcoma is a well-established fact. Clinically, the occurrence of non-mechanical pain or night pain at any age warrants concern and immediate further investigation. In fact, pain is typically the symptom that suggests a benign lesion may have become malignant. However, benign enchondromas can also cause pain, meaning that pain does not rule out the possibility of a benign enchondroma. Conversely, the absence of pain does not entirely exclude the diagnosis of chondrosarcoma [9]. Also, if the lesion is radiologically inactive and the patient doesn’t have any pain, a biopsy is not necessary. If the patient develops symptoms, the standard imaging investigation protocol for neoplastic lesions should be followed: CT scan of the TAP region plus the affected segment, scintigraphy of the entire skeleton, and MRI if necessary [9-10].

Distinguishing an enchondroma from a low-grade chondrosarcoma is challenging due to their histopathological similarity. Most enchondromas are small, between 1-3 cm, whereas a chondrosarcoma is larger, approximately 5 cm. If one or more mitotic figures are identified, it is highly indicative of malignancy [10-12]. Sustained pain associated with radiologically identified discontinuity of the bone cortex and invasion of the surrounding soft tissues further support the hypothesis of a malignancy [13-15]. However, the incidence of transformation is less in small bones (hand, feet) and is higher for the shoulder and pelvis. In solitary enchondromas, the risk for malignant transformation is less than 1%, while in multiple enchondromatosis the risk is between 5-25% [16,17].

Surgical treatment remains a topic of debate in patients diagnosed with enchondroma/atypical cartilaginous tumor: resection of the tumor with wide surgical margins or intralesional curettage which is also considered as adequate treatment according to the World Health Organisation [18,19].

Leerapun et al., in a study involving 70 patients, reported 13 cases treated with intralesional curettage and 57 cases with segmental resection. They observed one local recurrence in each group and found no difference in survival between the two treatment methods [20].

In our case, the bone lesion was resected within oncological limits, and the specimens were sent for histopathological examination. Timely intervention and regular follow-up resulted in a good outcome, and there were no signs of recurrence six moths post-surgery.

Conclusions

Enchondroma is a cartilage-originating benign tumor that is infrequently found in patients over 40 years old, with differential diagnosis being made with a malignant tumor formation, or chondrosarcoma. These tumors can be problematic when they become aggressive or occur in unusual locations when it comes to the choice of treatment. Solitary enchondromas that grow aggressively and become symptomatic should be treated surgically. The therapy of choice in enchondroma comprises non-surgical treatment (observation) if the lesion remains unaltered in imaging, or curettage/filling with bone substitutes/allografts, but considering the advanced age and interruption of the bone cortex in our case, we opted for curative surgical treatment.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study. Ethics Committee of University Emergency Hospital Bucharest issued approval no. 40570. The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of University Emergency Hospital Bucharest (no. 40570).

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Mihai Aurel Costache, Catalin Cirstoiu, Sergiu Iordache, Andreea Marinescu, Mihnea Popa

Acquisition, analysis, or interpretation of data:  Mihai Aurel Costache, Catalin Cirstoiu, Bogdan Serban, Sergiu Iordache, Adrian Cursaru, Bogdan Cretu, Andreea Marinescu, Mihnea Popa

Drafting of the manuscript:  Mihai Aurel Costache, Adrian Cursaru

Supervision:  Mihai Aurel Costache, Catalin Cirstoiu, Sergiu Iordache, Adrian Cursaru, Bogdan Cretu, Mihnea Popa

Critical review of the manuscript for important intellectual content:  Catalin Cirstoiu, Bogdan Serban, Sergiu Iordache, Adrian Cursaru, Bogdan Cretu, Andreea Marinescu, Mihnea Popa
==== Refs
References

1 Bone grafts versus synthetic bone substitutes in the treatment of benign bone tumors Rom J Orthop Surg Traumatol Mihai-Aurel C Andrei I Bogdan Ş Răzvan SD Gabriel PM Ştefan RA Adrian C 67 70 4 2021
2 How to diagnose enchondroma, bone infarct, and chondrosarcoma Curr Probl Diagn Radiol Mulligan ME 262 273 48 2019 29724496
3 Clavicular malignancies: a borderline surgical management Medicina (Kaunas) Nistor CE Ciuche A Cucu AP Serban B Cursaru A Cretu B Cirstoiu C 910 58 2022 35888630
4 Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton J Orthop Traumatol Campanacci DA Scoccianti G Franchi A 101 107 14 2013 23462877
5 Enchondroma in the diaphysis of tibia - A case report and review of its characteristics and differentials in the diaphysis J Orthop Case Rep Nayak KR Kulkarni MS Vijayan S Rao SK 6 11 11 2021 https://pubmed.ncbi.nlm.nih.gov/34790593/
6 Enchondroma Radiopaedia.org 8 2024 Gaillard F Walizai T Campos A 2024 https://radiopaedia.org/articles/enchondroma
7 Long bone enchondroma vs. low-grade chondrosarcoma: current concepts review Shafa Ortho J Jamshidi K Mirzaei A 9155 4 2017 https://www.researchgate.net/publication/310733686_Long_Bone_Enchondroma_vs_Low-Grade_Chondrosarcoma_Current_Concepts_Review
8 Incidental enchondromas of the knee AJR Am J Roentgenol Walden MJ Murphey MD Vidal JA 1611 1615 190 2008 18492914
9 Insights into enchondroma, enchondromatosis and the risk of secondary chondrosarcoma. Review of the literature with an emphasis on the clinical behaviour, radiology, malignant transformation and the follow up Neoplasma Herget GW Strohm P Rottenburger C 365 378 61 2014 http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=3792&category_id=109&option=com_virtuemart 24645839
10 Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma? Eur J Radiol Crim J Schmidt R Layfield L Hanrahan C Manaster BJ 2222 2230 84 2015 https://pubmed.ncbi.nlm.nih.gov/26220916/ 26220916
11 Enchondroma versus low-grade chondrosarcoma in appendicular skeleton: clinical and radiological criteria J Oncol Ferrer-Santacreu EM Ortiz-Cruz EJ González-López JM Pérez Fernández E 437958 2012 2012 https://onlinelibrary.wiley.com/doi/10.1155/2012/437958 22593766
12 Local recurrence management of extremity soft tissue sarcoma EFORT Open Rev Serban B Cretu B Cursaru A Nitipir C Orlov-Slavu C Cirstoiu C 606 614 8 2023 37526250
13 Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma AJR Am J Roentgenol Geirnaerdt MJ Hermans J Bloem JL Kroon HM Pope TL Taminiau AH Hogendoorn PC 1097 1104 169 1997 9308471
14 Solitary enchondromas: is radiographic follow-up sufficient in patients with asymptomatic lesions? Acta Orthop Belg Müller PE Dürr HR Wegener B Pellengahr C Maier M Jansson V 112 118 69 2003 https://pubmed.ncbi.nlm.nih.gov/12769010/ 12769010
15 Melorheostosis: a review of the literature and a case report Medicina (Kaunas) Iordache S Cursaru A Serban B Costache M Spiridonica R Cretu B Cirstoiu C 869 59 2023 37241101
16 Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities:80 patients followed for 2-25 years Acta Orthop Scand Bauer HC Brosjö O Kreicbergs A Lindholm J 283 288 66 1995 7604716
17 Enchondroma In: StatPearls [Internet] Biondi NL Tiwari V Varacallo M Treasure Island, FL StatPearls Publishing 2024 https://www.ncbi.nlm.nih.gov/books/NBK536938/
18 Radiologic follow-up of untreated enchondroma and atypical cartilaginous tumors in the long bones J Surg Oncol Deckers C Schreuder BH Hannink G de Rooy JW van der Geest IC 987 991 114 2016 27696436
19 Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function Clin Orthop Relat Res Mohler DG Chiu R McCall DA Avedian RS 2765 2773 468 2010 20574801
20 Surgical management of conventional grade I chondrosarcoma of long bones Clin Orthop Relat Res Leerapun T Hugate RR Inwards CY Scully SP Sim FH 166 172 463 2007 17632422
